Autoantigenesis: The evolution of protein modifications in autoimmune disease

Current Opinion in Immunology

Volumn 24, Issue 1, 2012, Pages 112-118

  Doyle, Hester A ^a   Mamula, Mark J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; PROTEIN; SELF PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; AUTOANTIGENESIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BIOLOGICAL FUNCTIONS; CELL SURFACE; CELLULAR IMMUNITY; EVOLUTION; EXTRACELLULAR SPACE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; INFLAMMATION; NONHUMAN; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN TARGETING; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIGEN PRESENTATION; AUTOANTIGENS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; T-LYMPHOCYTES;

EID: 84857045897     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2011.12.003     Document Type: Review

References (36)

1. Uy R., Wold F. Posttranslational covalent modifications of proteins. Science 1977, 198:890-896.
2. Wold F. In vivo chemical modification of proteins (post-translational modification). Annu Rev Biochem 1981, 50:783-814.
3. Derbinski J., Schulte A., Kyewski B., Klein L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol 2001, 2:1032-1039.
4. Iversen O.J., Lysvand H., Hagen L. The autoantigen Pso p27: a post-translational modification of SCCA molecules. Autoimmunity 2011, 44:229-234.
5. Pedchenko V., Vanacore R., Hudson B. Goodpasture's disease: molecular architecture of the autoantigen provides clues to etiology and pathogenesis. Curr Opin Nephrol Hypertens 2011, 20:290-296.
6. Mor-Vaknin N., Kappes F., Dick A.E., Legendre M., Damoc C., Teitz-Tennenbaum S., Kwok R., Ferrando-May E., Adams B.S., Markovitz D.M. DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigen. Arthritis Rheum 2011, 63:556-567.
7. Stadinski B.D., Delong T., Reisdorph N., Reisdorph R., Powell R.L., Armstrong M., Piganelli J.D., Barbour G., Bradley B., Crawford F., et al. Chromogranin A is an autoantigen in type 1 diabetes. Nat Immunol 2010, 11:225-231.
8. Haskins K., Cooke A. CD4 T cells and their antigens in the pathogenesis of autoimmune diabetes. Curr Opin Immunol 2011, 23:1-7.
9. Wiik A.S., van Venrooij W.J., Pruijn G.J. All you wanted to know about anti-CCP but were afraid to ask. Autoimmun Rev 2010, 10:90-93.
10. Mydel P., Wang Z., Brisslert M., Hellvard A., Dahlberg L.E., Hazen S.L., Bokarewa M. Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis. J Immunol 2010, 184:6882-6890.
11. Neugebauer K.M., Merrill J.T., Wener M.H., Lahita R.G., Roth M.B. SR proteins are autoantigens in patients with systemic lupus erythematosus: importance of phosphoepitopes. Arthritis Rheum 2000, 43:1768-1778.
12. Chui D., Sellakumar G., Green R.S., Sutton-Smith M., McQuistan T., Marek K.W., Morris H.R., Dell A., Marth J.D. Genetic remodeling of protein glycosylation in vivo induces autoimmune disease. Proc Natl Acad Sci U S A 2001, 98:1142-1147.
13. Zamvil S.S., Mitchell D.J., Moore A.C., Kitamura K., Steinman L., Rothbard J.B. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature 1986, 324:258-260.
14. Mamula M.J., Gee R.J., Elliot J.I., Sette A., Southwood S., Jones P., Blier P.R. Isoaspartyl post-translational modification triggers autoimmune responses to self-proteins. J Biol Chem 1999, 274:22321-22327.
15. Najbauer J., Orpiszewski J., Aswad D.W. Molecular aging of tubulin: accumulation of isoaspartyl sites in vivo. Biochemistry 1996, 35:5183-5190.
16. Takemoto L.J. Degradation of aspartyl and asparaginyl residues of lens proteins in vivo. Deamidation and Isoaspartate formation in Peptides and Proteins 1995, 157-165. CRC Press. D.W. Aswad (Ed.).
17. van Stipdonk M.J.B., Willems A.A., Amour S., Persoon-Deen C., Travers P.J., Boog J.P., van Noort J.D. T cells discriminate between differentially phosphorylated forms of αB-crystallin, a major central nervous system myelin antigen. Int Immunol 1998, 10:943-950.
18. 2+-free calmodulin and calmodulin damaged by in vitro aging are selectively degraded by 26 S proteasome without ubiquitination. J Biol Chem 2000, 275:20295-20301.
19. Leib S.L., Kim Y.S., Chow L.L., Sheldon R.A., Tauber M.G. Reactive oxygen intermediates contribute to necrotic and apoptotic neuronal injury in an infant rat model of bacterial meningitis due to group B streptococci. J Clin Invest 1996, 98:2632-2639.
20. Rathmell J.C., Thompson C.B. The central effectors of cell death in the immune system. Annu Rev Immunol 1999, 17:781-828.
21. Hershko A., Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998, 67:425-479.
22. Asaga H., Yamada M., Senshu T. Selective deimination of vimentin in calcium ionophor-induced apoptosis of mouse peritoneal macrophages. Biochem Biophys Res Commun 1998, 243:641-646.
23. Andrade F., Casciola-Rosen L., Rosen A. Apoptosis in systemic lupus erythematosus. Clinical implications. Rheum Dis Clin North Am 2000, 26. 215-227, v.
24. Utz P.J., Gensler T.J., Anderson P. Death, autoantigen modifications, and tolerance. Arthritis Res 2000, 2:101-114.
25. Casciola-Rosen L.A., Anhalt G., Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994, 179:1317-1330.
26. Gensler T.J., Hottelet M., Zhang C., Schlossman S., Anderson P., Utz P.J. Monoclonal antibodies derived from BALB/C mice immunized with apoptotic Jurkat T cells recognize known autoantigens. J Autoimmun 2001, 16:59-69.
27. Utz P.J., Hottelet M., Schur P.H., Anderson P. Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J Exp Med 1997, 185:843-854.
28. Zampieri S., Degen W., Ghirardello A., Doria A., Venrooij W.Jv. Dephosphorylation of autoantigenic ribosomal P proteins during Fas-L induced apoptosis: a possible trigger for the development of the autoimmune response in patients with systemic lupus erythematosus. Ann Rheum Dis 2001, 60:72-76.
29. Gahring L.C., Carlson N.G., Meyer E.L., Rogers S.W Granzyme B proteolysis of a neuronal glutamate receptor generates an autoantigen and is modulated by glycosylation. J Immunol 2001, 166:1433-1438.
30. Johnson B.A., Aswad D.W. Fragmentation of isoaspartyl peptides and proteins by carboxypeptidase Y: release of isoaspartyl dipeptides as a result of internal and external cleavage. Biochemistry 1990, 29:4373-4380.
31. Moss C.X., Matthews S.P., Lamont D.J., Watts C. Asparagine deamidation perturbs antigen presentation on class II major histocompatibility complex molecules. J Biol Chem 2005, 280:18498-18503.
32. Doyle H.A., Gee R.J., Mamula M.J. Altered immunogenicity of isoaspartate containing proteins. Autoimmunity 2007, 40:131-137.
33. Pritzker L.B., Joshi S., Gowan J.J., Harauz G., Moscarello M.A. Deimination of myelin basic protein. 1. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D. Biochemistry 2000, 39:5374-5381.
34. Demetriou M., Granovsky M., Quaggin S., Dennis J.W. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 2001, 409:733-739.
35. Sahin U., Tureci O., Schmitt H., Cochlovius B., Hohannes T., Schmits R., Stenner F., Luo G., Schobert I., Pfreundschuh M. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci U S A 1995, 92:11810-11813.
36. Ioannou Y., Zhang J.Y., Qi M., Gao L., Qi J.C., Yu D.M., Lau H., Sturgess A.D., Vlachoyiannopoulos P.G., Moutsopoulos H.M., et al. Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen beta2-glycoprotein I. Arthritis Rheum 2011, 63:2774-2782.